Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles

By Vauthier C.   Dubernet C.   Chauvierre C.   Brigger I.   Couvreur P.  

Journal of Controlled Release, Vol. 93, Iss. 2, 2003-12 ,pp. : 151-160

Elsevier

Access to resources Recommend Favorite

Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays

By De Juan Berta Sanchez   Von Briesen Hagen   Gelperina Svetlana   Kreuter Jorg  

Journal of Drug Targeting, Vol. 14, Iss. 9, 2006-11 ,pp. : 614-622

Informa Healthcare

Access to resources Recommend Favorite

Enhanced bioavailability of orally administered flurbiprofen by combined use of hydroxypropyl-cyclodextrin and poly(alkyl-cyanoacrylate) nanoparticles

By Zhao Xiaoyun   Li Wei   Luo Qiuhua   Zhang Xiangrong  

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 39, Iss. 1, 2014-03 ,pp. : 61-67

Springer Publishing Company

Access to resources Recommend Favorite

Enhanced Tumour Uptake of Doxorubicin Loaded Poly(butyl cyanoacrylate) Nanoparticles in Mice Bearing Dalton's Lymphoma Tumour

By Reddy L. Harivardhan   Sharma R. K.   Murthy R. S. R.  

Journal of Drug Targeting, Vol. 12, Iss. 7, 2004-08 ,pp. : 443-451

Informa Healthcare

Access to resources Recommend Favorite

Arylsulfatase A bound to poly(butyl cyanoacrylate) nanoparticles for enzyme replacement therapy – physicochemical evaluation

By Mühlstein A.   Gelperina S.   Shipulo E.   Maksimenko O.   Kreuter J.  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 7, 2014-07 ,pp. : 518-524

Govi-Verlag

Access to resources Recommend Favorite